Inhibitor Therapeutics Stock Alpha and Beta Analysis
| INTI Stock | USD 0.04 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Inhibitor Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Inhibitor Therapeutics over a specified time horizon. Remember, high Inhibitor Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Inhibitor Therapeutics' market risk premium analysis include:
Beta (1.02) | Alpha 0.32 | Risk 9.41 | Sharpe Ratio 0.0243 | Expected Return 0.23 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Inhibitor |
Inhibitor Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Inhibitor Therapeutics market risk premium is the additional return an investor will receive from holding Inhibitor Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Inhibitor Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Inhibitor Therapeutics' performance over market.| α | 0.32 | β | -1.02 |
Inhibitor Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Inhibitor Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Inhibitor Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Inhibitor Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Inhibitor Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibitor Therapeutics shares will generate the highest return on investment. By understating and applying Inhibitor Therapeutics otc stock market price indicators, traders can identify Inhibitor Therapeutics position entry and exit signals to maximize returns.
Inhibitor Therapeutics Return and Market Media
The median price of Inhibitor Therapeutics for the period between Tue, Sep 30, 2025 and Mon, Dec 29, 2025 is 0.05 with a coefficient of variation of 7.62. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.05, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Inhibitor Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Inhibitor or other otcs. Alpha measures the amount that position in Inhibitor Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inhibitor Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inhibitor Therapeutics' short interest history, or implied volatility extrapolated from Inhibitor Therapeutics options trading.
Build Portfolio with Inhibitor Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Inhibitor OTC Stock
Inhibitor Therapeutics financial ratios help investors to determine whether Inhibitor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inhibitor with respect to the benefits of owning Inhibitor Therapeutics security.